Adverse events of injected CGRP inhibitors

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1913卷 / 1期
关键词：
D O I：
10.1007/s40278-022-18151-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [1] Adverse events of PARP inhibitors
    Romanova, M.
    Klat, J.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2021, 86 (01): : 54 - 60
  • [2] Adverse events with JAK inhibitors
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (02): : E71 - E71
  • [3] A Review of Amputation and Gangrene Adverse Events for Injected Promethazine
    Altman, Keith L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S164 - S164
  • [4] Adverse events associated with JAK inhibitors
    Hoisnard, L.
    Sbidian, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 7 - 8
  • [5] Adverse Events of Immune Checkpoint Inhibitors
    Foller, S.
    Oppel-Heuchel, H.
    Fetter, I.
    Winkler, Y.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (04): : 486 - 491
  • [6] Tirosine Kinase Inhibitors Adverse Events
    Campiotti, Leonardo
    Maresca, Andrea
    Guasti, Luigina
    Grandi, Anna Maria
    ONCOLOGIST, 2014, 19 (03): : 306 - 306
  • [7] Adverse events associated with mTOR inhibitors
    Pallet, Nicolas
    Legendre, Christophe
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (02) : 177 - 186
  • [8] Aromatase inhibitors and musculoskeletal adverse events
    Liedke, Pedro E. R.
    Goss, Paul E.
    LANCET ONCOLOGY, 2012, 13 (04): : 333 - 334
  • [9] Adverse Events of Tumor Necrosis Factor Inhibitors
    Fellermann, Klaus
    DIGESTIVE DISEASES, 2013, 31 (3-4) : 374 - 378
  • [10] Endocrine adverse events of immune checkpoint inhibitors
    Merlen, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2023, 27 (4-5): : 128 - 131
12345